Strikingly, ProB-ALL leukemic cells show higher expression levels of myeloid markers such as CD66c, CD33 and the immaturity marker CD123, along with the apparent downregulation of CD20, CD38, CD81 and CD24 expression. This evidence concerns the gene CD33 and acute lymphoblastic leukemia.